João Pedro Ferreira Selected Research

João Pedro Ferreira Research Topics

Disease

181	Heart Failure 05/2024 - 10/2013
31	Myocardial Infarction 12/2023 - 02/2017
20	Fibrosis (Cirrhosis) 03/2024 - 01/2018
20	Type 2 Diabetes Mellitus (MODY) 03/2024 - 01/2020
15	Stroke (Strokes) 12/2023 - 08/2016
13	Inflammation (Inflammations) 01/2024 - 01/2019
12	Hypertension (High Blood Pressure) 12/2022 - 10/2017
11	Atrial Fibrillation 12/2023 - 08/2016
9	Cardiomyopathies (Cardiomyopathy) 04/2024 - 01/2016
9	Chronic Renal Insufficiency 03/2024 - 11/2016
9	Left Ventricular Dysfunction 04/2022 - 01/2018
8	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023 - 05/2017
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2018
7	Acute Coronary Syndrome 11/2023 - 01/2018
7	Hyperkalemia 01/2023 - 01/2018
6	Respiratory Sounds (Crackle) 11/2022 - 05/2019
5	Diabetes Mellitus 12/2022 - 05/2017
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2024 - 01/2020
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2024 - 01/2017
4	Body Weight (Weight, Body) 07/2023 - 04/2022
4	Obesity 07/2023 - 01/2020
4	Albuminuria 11/2022 - 03/2014
4	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2022 - 11/2019
4	Hemorrhage 01/2021 - 08/2016
4	Hypotension (Low Blood Pressure) 01/2021 - 01/2020
3	COVID-19 03/2024 - 02/2021
3	Necrosis 11/2023 - 01/2022
3	ST Elevation Myocardial Infarction 10/2023 - 01/2018
3	Hypokalemia 01/2023 - 01/2020
3	Gout 01/2023 - 01/2022
3	Acute Kidney Injury (Acute Renal Failure) 01/2023 - 02/2021
3	Anemia 11/2022 - 01/2018
3	Prediabetic State (Prediabetes) 01/2022 - 01/2021
3	Systolic Heart Failure 01/2021 - 01/2018
3	Renal Insufficiency (Renal Failure) 01/2021 - 01/2019
2	Dyspnea (Shortness of Breath) 01/2024 - 09/2023
2	Atherosclerosis 01/2024 - 01/2019
2	Vascular Diseases (Vascular Disease) 10/2023 - 01/2021
2	Overweight 07/2023 - 01/2022
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2023 - 05/2019
2	Weight Loss (Weight Reduction) 01/2023 - 04/2022
2	Hyperuricemia 01/2023 - 01/2022
2	Sudden Death 10/2022 - 11/2020
2	Neoplasms (Cancer) 01/2022 - 01/2019
2	Isolated Systolic Hypertension 11/2021 - 07/2021

Drug/Important Bio-Agent (IBA)

57	empagliflozinIBA 04/2024 - 01/2019
36	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2014
30	Spironolactone (Aldactone)FDA LinkGeneric 03/2024 - 03/2014
21	Brain Natriuretic Peptide (Natrecor)FDA Link 03/2024 - 03/2014
21	Mineralocorticoid Receptor AntagonistsIBA 11/2023 - 01/2014
21	Eplerenone (Inspra)FDA LinkGeneric 01/2023 - 01/2018
16	SodiumIBA 12/2023 - 06/2016
16	Natriuretic PeptidesIBA 12/2023 - 12/2016
15	CreatinineIBA 01/2023 - 11/2016
14	Sodium-Glucose Transport ProteinsIBA 04/2024 - 01/2021
12	pro-brain natriuretic peptide (1-76)IBA 03/2024 - 01/2018
12	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2023 - 01/2020
12	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 01/2020
12	DiureticsIBA 06/2023 - 10/2013
11	PotassiumIBA 01/2023 - 01/2018
10	CollagenIBA 05/2024 - 01/2018
10	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2019
10	AlbuminsIBA 01/2023 - 01/2018
9	Glucagon-Like Peptide-1 Receptor AgonistsIBA 08/2023 - 01/2022
8	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023 - 01/2019
6	Insulin (Novolin)FDA Link 04/2024 - 04/2019
6	Troponin T (Troponin T1)IBA 12/2023 - 01/2014
6	Uric Acid (Urate)IBA 01/2023 - 10/2020
6	Procollagen Type IIBA 01/2023 - 01/2019
5	SymportersIBA 12/2023 - 01/2021
5	RivaroxabanIBA 12/2023 - 11/2019
5	procollagen type I carboxy terminal peptide (PICP)IBA 12/2023 - 01/2019
5	Hemoglobins (Hemoglobin)IBA 01/2023 - 04/2016
5	TroponinIBA 11/2022 - 01/2014
5	Angiotensin Receptor AntagonistsIBA 11/2022 - 01/2019
5	alogliptinIBA 07/2021 - 01/2020
4	AldosteroneIBA 10/2023 - 01/2018
4	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2023 - 01/2020
4	Losartan (Cozaar)FDA LinkGeneric 01/2023 - 01/2018
4	Collagen Type I (Type I Collagen)IBA 01/2023 - 01/2021
4	procollagen Type III-N-terminal peptide (PIIP)IBA 01/2022 - 01/2019
4	Collagen Type III (Type III Collagen)IBA 01/2022 - 01/2019
4	Antihypertensive Agents (Antihypertensives)IBA 11/2021 - 05/2017
4	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021 - 01/2020
4	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2020 - 06/2016
3	C-Reactive ProteinIBA 01/2024 - 01/2022
3	omega-Chloroacetophenone (Mace)IBA 01/2024 - 02/2021
3	Glucagon-Like Peptide 1 (GLP 1)IBA 07/2023 - 01/2022
3	dapagliflozinIBA 01/2023 - 01/2020
3	Neprilysin (Neutral Endopeptidase)IBA 01/2023 - 01/2020
3	Valsartan (Vals)FDA Link 01/2021 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2024 - 11/2023
2	fibrin fragment D (D-dimer)IBA 12/2023 - 01/2021
2	Growth Differentiation Factor 15IBA 11/2023 - 01/2020
2	AdrenomedullinIBA 11/2023 - 01/2021
2	rGLP-1 proteinIBA 01/2023 - 10/2022
2	Hormones (Hormone)IBA 01/2023 - 11/2022
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 07/2021

Therapy/Procedure

50	Therapeutics 11/2023 - 10/2013
2	Patient Readmission 01/2023 - 01/2020